Policy
-
Policy Matters
The FDA Takes Steps to Curb Tobacco UseThe federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.
by Nicholas Warren, PhD
-
Preconceived Notions: Cancer, Fertility Coverage and the LawInsurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.
by Shelly Rosenfeld
-
Open Medical Records: Pros and ConsPatients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
Policy Matters
COVID-19 Vaccines Are the Key to Restoring Momentum Against CancerCancer screenings and clinical trials have been seriously disrupted by the pandemic.
by Nicholas Warren, PhD
-
Hope for Cancer Health EquityHealth care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
-
Rethinking Access to Disability BenefitsAdvances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.
by Jen Tota McGivney
-
April 30: The Week in Cancer NewsPresident Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.
by Bradley Jones
-
Forward Look
Making Cancer Clinical Trials More InclusiveDespite efforts by policymakers, a gender gap persists in clinical trial participation.
by Lindsey Konkel
-
Policy Matters
Research Advocacy During COVID-19Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
-
Q&A
Up for DebateHematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
